Herbas VPB

Print
EN | LT
LT - Vandeninė vaisto forma, apimanti 1-(4-{[4-(dimetilamino)piperidin-1- il] karbonil}fenil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)fenil]karbamidą
EN - AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/00 (2006.01)
A61K 9/08 (2006.01)
A61K 9/19 (2006.01)
A61K 31/5377 (2006.01)
A61K 47/12 (2006.01)
A61K 47/40 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 3810089
(13) Kind of document T
(96) European patent application number 19742898.0
Date of filing the European patent application 2019-06-04
(97) Date of publication of the European application 2021-04-28
(45) Date of publication and mention of the grant of the patent 2023-08-02
(46) Date of publication of the claims translation 2023-11-10
PCT application
(86) Number PCT/IB2019/054643
Date 2019-06-04
PCT application publication
(87) Number WO 2019/234632
Date 2019-12-12
Priority applications
(30) Number Date Country code
201862681722 P 2018-06-07 US
201862754651 P 2018-11-02 US
201962796133 P 2019-01-24 US
201962841882 P 2019-05-02 US
Inventors
(72)
HUSSEY, James Joseph , GB
BRIGHT, Andrew Gilbert , GB
Grantee
(73) Pfizer Inc. , 66 Hudson Boulevard East, New York, NY 10001-2192, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Vandeninė vaisto forma, apimanti 1-(4-{[4-(dimetilamino)piperidin-1- il] karbonil}fenil)-3-[4-(4,6-dimorfolin-4-il-1,3,5-triazin-2-il)fenil]karbamidą
  AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA
Last renewal fee
Payment date Validity (years) Amount
2025-05-20 7 162.00 EUR
Next renewal fee
2026-06-04